搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
pharmaphorum
15 分钟
Pharmacy benefits: Lessons from 2024 and what lies ahead for 2025
The healthcare industry experienced a rollercoaster of a year in 2024, with pharmacy benefits undergoing significant shifts.
pharmaphorum
17 分钟
Novo Nordisk leaps on new obesity drug data
Novo Nordisk is currently leading the market for incretin therapies with semaglutide-based products Ozempic for type 2 ...
pharmaphorum
59 分钟
Neko Health raises $260m for its bid to transform healthcare
The new business venture of Spotify founder Daniel Ek – Neko Health – has raised $260 million to bring its full body-scanning ...
pharmaphorum
1 小时
AstraZeneca reveals $570m investment in Canada
AstraZeneca has unveiled plans to invest around $570 million in Canada and add around 700 new jobs, describing the county as ...
pharmaphorum
1 小时
AstraZeneca is planning $570m investment in Canada
AstraZeneca has unveiled plans to invest around $570 million in Canada and add around 700 new jobs, describing the county as ...
pharmaphorum
1 小时
2025 digital transformation budgets: Realigning expectations
In fact, a McKinsey study found that “while 90% of companies have launched some flavour of digital transformation, only a ...
pharmaphorum
2 小时
UnitedHealth names CEO to replace slain Thompson
US health insurance giant UnitedHealth Group has appointed company veteran Tim Noel as chief executive of UnitedHealthcare, ...
pharmaphorum
4 小时
Purdue and Sacklers agree new $7.4bn opioid settlement
Purdue Pharma and the Sackler family who own the company have proposed a new $7.4 billion settlement to resolve thousands of ...
pharmaphorum
23 小时
US/EU regulators start review of Biogen's high-dose Spinraza
Spinraza remains a big product for Biogen, but has seen its sales go into reverse as competition in SMA treatment has emerged ...
pharmaphorum
20 小时
Rare disease and the women's health gap
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jennifer Schranz, head of rare diseases at Ipsen, for a ...
pharmaphorum
1 天
AMR biotech BioVersys plans to float on Swiss stock exchange
BV100 is a new formulation of rifabutin suitable for intravenous administration, which BioVersys claims offers a new ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈